Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today

In the latest close session, Oscar Health, Inc. (OSCR) was down 3.97% at $16.69. This change lagged the S&P 500's daily loss of 0.53%. Elsewhere, the Dow saw a downswing of 0.09%, while the tech-heavy Nasdaq depreciated by 1%. Coming into today, shares of the company had gained 10.63% in the past month. In that same time, the Finance sector gained 0.87%, while the S&P 500 gained 2.06%. Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on February 10, 2026. The company's earnings per share (EPS) are projected to be -$0.84, reflecting a 35.48% decrease from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $3.21 billion, up 33.98% from the year-ago period. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.35 per share and revenue of $12.1 billion, indicating changes of -1450% and 0%, respectively, compared to the previous year. Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability. Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold). The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 80, finds itself in the top 33% echelons of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Just Released: Zacks Top 10 Stocks for 2026Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks